A study in healthy male subjects to understand how savolitinib when taken with midazolam behaves inside the body

Trial Identifier: D5084C00004
Sponsor: AstraZeneca
NCTID:: NCT04187456
Start Date: December 2019
Primary Completion Date: March 2020
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United States of America, MD Baltimore, MD, United States of America, 21225